Open access
Open access
Powered by Google Translator Translator

Infectious Diseases (all articles)

The Delta Covid variant and children: transmission in kids is low and only 2% hospitalized, report finds.

12 Sep, 2021 | 21:56h | UTC

The Delta Covid variant and children: transmission in kids is low and only 2% hospitalised, report finds – The Guardian

Report: COVID-19 Delta variant in schools and early childhood education and care services in NSW, Australia: 16 June to 31 July 2021 – NCIRS

News release: COVID-19 Delta variant in schools and early childhood education and care services in NSW, Australia: 16 June to 31 July 2021

 

Commentary on Twitter (thread – click for more)

 


RCT: Convalescent plasma does not improve outcomes and may be harmful to hospitalized patients with COVID-19.

10 Sep, 2021 | 05:37h | UTC

Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial – Nature Medicine

News release: Major study finds convalescent plasma doesn’t help seriously ill COVID-19 patients – McMaster University

Related:

NIH study shows no significant benefit of convalescent plasma for COVID-19 outpatients with early symptoms.

M-A: Convalescent plasma is safe but does not improve outcomes in the treatment of COVID-19.

RECOVERY Trial: No benefit from convalescent plasma in patients admitted to hospital with COVID-19.

 

Commentary on Twitter

 


Face masks for COVID pass their largest test yet – “A rigorous study finds that surgical masks are highly protective, but cloth masks fall short”.

10 Sep, 2021 | 05:36h | UTC

Face masks for COVID pass their largest test yet – Nature

Original study: [Preprint] Largest study of masks yet details their importance in fighting Covid-19.

 

Commentary on Twitter

 


Covid-19: Infection increases the risk of kidney disease even in mild cases, finds study.

10 Sep, 2021 | 05:33h | UTC

Covid-19: Infection increases the risk of kidney disease even in mild cases, finds study – The BMJ

Original study: Kidney Outcomes in Long COVID – Journal of the American Society of Nephrology

 


Long COVID and kidney disease.

10 Sep, 2021 | 05:31h | UTC

Long COVID and kidney disease – Nature Reviews Nephrology

 


COVID infections may give more potent immunity than vaccines – but that doesn’t mean you should try to catch it.

10 Sep, 2021 | 05:29h | UTC

COVID infections may give more potent immunity than vaccines – but that doesn’t mean you should try to catch it – The Conversation

Original study and commentary: [Preprint] Observational data suggests natural immunity after a SARS-CoV-2 infection confers longer lasting and stronger protection compared to vaccine-induced immunity.

 


India’s DNA COVID vaccine is a world first – more are coming.

10 Sep, 2021 | 05:30h | UTC

India’s DNA COVID vaccine is a world first – more are coming – Nature

 


What an enormous global study can tell us about feeling better during the pandemic.

10 Sep, 2021 | 05:27h | UTC

What an enormous global study can tell us about feeling better during the pandemic – Vox

Original study: A multi-country test of brief reappraisal interventions on emotions during the COVID-19 pandemic – Nature Human Behavior

 


Perspective | What we actually know about waning immunity.

10 Sep, 2021 | 05:26h | UTC

What We Actually Know About Waning Immunity – The Atlantic

 


Economic impact of tuberculosis mortality in 120 countries and the cost of not achieving the Sustainable Development Goals tuberculosis targets: a full-income analysis.

10 Sep, 2021 | 05:18h | UTC

Economic impact of tuberculosis mortality in 120 countries and the cost of not achieving the Sustainable Development Goals tuberculosis targets: a full-income analysis – The Lancet Global Health

Invited Commentary: The incalculable costs of tuberculosis

 

Commentaries on Twitter

 


[Preprint] Ineffective neutralization of the SARS-CoV-2 Mu variant by convalescent and vaccine sera.

9 Sep, 2021 | 10:02h | UTC

Ineffective neutralization of the SARS-CoV-2 Mu variant by convalescent and vaccine sera – bioRxiv

Related: United States boosts tracking of coronavirus strains as Mu variant draws scrutiny – Science

 

Commentary on Twitter (thread – click for more)

 


Two observational studies suggest spontaneous abortion is not increased following COVID-19 mRNA vaccination during pregnancy.

9 Sep, 2021 | 10:04h | UTC

Study 1: Spontaneous Abortion Following COVID-19 Vaccination During Pregnancy – JAMA

Study 2: Receipt of mRNA Covid-19 Vaccines and Risk of Spontaneous Abortion – New England Journal of Medicine

 

Commentary on Twitter

 


[Preprint] RCT: Additional heterologous vs. homologous booster vaccination in immunosuppressed patients without SARS-CoV-2 antibody seroconversion after primary mRNA vaccination.

9 Sep, 2021 | 09:55h | UTC

Additional heterologous versus homologous booster vaccination in immunosuppressed patients without SARS-CoV-2 antibody seroconversion after primary mRNA vaccination: a randomized controlled trial – medRxiv

 

Commentary on Twitter (thread – click for more)

https://twitter.com/hildabast/status/1435720202147143680

 


AstraZeneca bosses warn against rush for boosters – “giving the most vulnerable, who may not have built up a full immune response from the first two, a third, top-up dose is “sensible”. But any decision to give a third, booster jab “to large swathes of the population”, to extend their protection from the first two, must be based on clinical data”.

9 Sep, 2021 | 09:59h | UTC

AstraZeneca bosses warn against rush for boosters – BBC

 

Commentary on Twitter (thread – click for more)

 


WHO appeals for countries to postpone COVID-19 vaccine boosters until 2022 to prioritize vaccinating the most at-risk people around the world who are yet to receive their first dose.

9 Sep, 2021 | 10:00h | UTC

WHO Appeals to Postpone COVID-19 Vaccine Boosters Until 2022; Tedros Lashes out at Pharma Association – Health Policy Watch

See also:

WHO chief urges halt to booster shots for rest of the year – Associated Press

WHO extends moratorium on booster COVID vaccine doses – CIDRAP

 


Perspective | The plan to stop every respiratory virus at once – “The benefits of ventilation reach far beyond the coronavirus. What if we stop taking colds and flus for granted, too?”

9 Sep, 2021 | 09:54h | UTC

The Plan to Stop Every Respiratory Virus at Once – The Atlantic

Related:

Recommendations for ventilation of indoor spaces to reduce COVID-19 transmission.

We studied how to reduce airborne COVID spread in hospitals. Here’s what we learnt.

Report: Improved ventilation essential to safe use of buildings and public spaces, say leading engineers.

WHO: Roadmap to improve and ensure good indoor ventilation in the context of COVID-19

CDC releases new ventilation guidelines for indoor environments to reduce Covid-19 risk

Guidance: Using Ventilation and filtration to reduce aerosol transmission of COVID-19 in long-term care homes

 


Balancing incentives and disincentives for vaccination in a pandemic.

9 Sep, 2021 | 09:52h | UTC

Balancing incentives and disincentives for vaccination in a pandemic – Nature Medicine

Related: Opinion | COVID vaccines: we need to find out which incentives actually work – the author argues that policies to promote vaccine uptake should be tested in randomized clinical trials.

 


A large observational study suggests eating a plant-rich diet could reduce the risk of developing severe COVID-19.

9 Sep, 2021 | 09:51h | UTC

Eating a plant rich diet reduces risk of developing COVID-19 – King’s College London

Original study: Diet quality and risk and severity of COVID-19: a prospective cohort study – Gut

 


RCT: A Seven-days course of antibiotics for the treatment of bloodstream infections by Enterobacterales was noninferior to a 14-days course.

9 Sep, 2021 | 09:03h | UTC

Seven versus 14-days course of antibiotics for the treatment of bloodstream infections by Enterobacterales. A randomized, controlled trial – Clinical Microbiology and Infection

 

Commentary on Twitter

 


Spread of Delta SARS-CoV-2 variant driven by a combination of immune escape and increased infectivity.

7 Sep, 2021 | 21:49h | UTC

News release: Spread of Delta SARS-CoV-2 variant driven by combination of immune escape and increased infectivity – University of Cambridge

Original article: SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion – Nature

 


Cochrane review: evidence is insufficient to draw meaningful conclusions if SARS‐CoV‐2-specific monoclonal antibodies are effective in the treatment of COVID-19.

7 Sep, 2021 | 21:51h | UTC

Summary: Are laboratory-made, COVID-19-specific monoclonal antibodies an effective treatment for COVID-19? – Cochrane Library

Original review: SARS‐CoV‐2‐neutralising monoclonal antibodies for treatment of COVID‐19 – Cochrane Library

 


Chile authorizes Sinovac vaccine for kids of 6 and older.

7 Sep, 2021 | 21:45h | UTC

Chile authorizes Sinovac vaccine for kids of 6 and older – Associated Press

 


Kids and COVID: why young immune systems are still on top.

7 Sep, 2021 | 21:46h | UTC

Kids and COVID: why young immune systems are still on top – Nature

 


Study shows high effectiveness of the Pfizer mRNA COVID-19 vaccine in pregnancy.

7 Sep, 2021 | 21:48h | UTC

Effectiveness of the BNT162b2 mRNA COVID-19 vaccine in pregnancy – Nature Medicine

 

Commentaries on Twitter

 


[Preprint] M-A of 12.011.447 individuals finds individuals previously infected with SARS-CoV-2 had an 81% reduction in odds of a reinfection.

7 Sep, 2021 | 21:42h | UTC

The prevalence of adaptive immunity to COVID-19 and reinfection after recovery, a comprehensive systematic review and meta-analysis of 12 011 447 individuals – medRxiv

 

Commentary on Twitter

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.